Skip to main content
Tech.euFundingExplorerBeta

tacalyx

Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA

Berlin, Germanywww.tacalyx.com ↗
Healthtech
← All companies
Total raised
€18M
€18,000,000
Funding rounds
2
Investors
7
distinct backers
Active since
2019-09
latest 2026-04

Funding by year

EUR raised per year · 2026 YTD

Signals

High confidence
Raise-next likelihood32
base rate 44% for Seed
  • ▼ Raised very recently
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
  • ▲ 7y since founding

Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2026-04-30Seed€11MBoehringer Ingelheim Venture Fund (BIVF),Creathor Ventures,Eurazeo,High-Tech Gründerfonds (HTGF),Kurma Partners,Thuja CapitalView deal →
2019-10-01Seed€7.0MBoehringer Ingelheim Venture Fund,Kurma PartnersView deal →

Investors

7
Boehringer Ingelheim Venture FundBoehringer Ingelheim Venture Fund (BIVF)Creathor VenturesEurazeoHigh-Tech Gründerfonds (HTGF)Kurma PartnersThuja Capital

Related news

Similar companies

same sector or country